Pharmaceutical Industry Information Portal

HomeTagsRDIF

All posts by tag

RDIF

Clinical trials in Russia and Azerbaijan of the combination of AstraZeneca and Sputnik Light vaccines showed safety

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), R-Pharm group and AstraZeneca announce interim results of phase II clinical trials to evaluate...

Vaccine against COVID Sputnik V granted full permanent approval in Russia

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that the Russian Sputnik V vaccine against coronavirus has been granted full permanent...

New investments in the innovative biotechnology company “Target Medicals”

RDIF, AstraZeneca and Unicorn Capital Partners invest in Target Medicals, developing aldosterone synthase inhibitor for the treatment of resistant arterial hypertension. The Russian Direct Investment...

Spallanzani Institute in Italy: Sputnik V shows higher Omicron-antibody levels than Pfizer in preliminary study

The Gamaleya National Research Center of Epidemiology and Microbiology (Gamaleya Center) and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund, investor in...

The combination of AstraZeneca and Sputnik Light vaccines in Azerbaijan shows strong neutralizing antibodies growth

R-Pharm Group, the Russian Direct Investment Fund (RDIF) and AstraZeneca announce preliminary virus neutralizing activity results of combined use of the AstraZeneca vaccine (developed...

The single-component Sputnik Light vaccine authorized in Armenia

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by...
spot_img

Expert Articles

spot_img